Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
XWMRR3MVTwd6LjH5
